JP2012065652A5 - - Google Patents

Download PDF

Info

Publication number
JP2012065652A5
JP2012065652A5 JP2011214253A JP2011214253A JP2012065652A5 JP 2012065652 A5 JP2012065652 A5 JP 2012065652A5 JP 2011214253 A JP2011214253 A JP 2011214253A JP 2011214253 A JP2011214253 A JP 2011214253A JP 2012065652 A5 JP2012065652 A5 JP 2012065652A5
Authority
JP
Japan
Prior art keywords
cells
sendai virus
vector
cell
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011214253A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012065652A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2011214253A priority Critical patent/JP2012065652A/ja
Priority claimed from JP2011214253A external-priority patent/JP2012065652A/ja
Publication of JP2012065652A publication Critical patent/JP2012065652A/ja
Publication of JP2012065652A5 publication Critical patent/JP2012065652A5/ja
Pending legal-status Critical Current

Links

JP2011214253A 2003-11-04 2011-09-29 遺伝子導入された樹状細胞の製造方法 Pending JP2012065652A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011214253A JP2012065652A (ja) 2003-11-04 2011-09-29 遺伝子導入された樹状細胞の製造方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2003374808 2003-11-04
JP2003374808 2003-11-04
JP2004187028 2004-06-24
JP2004187028 2004-06-24
JP2011214253A JP2012065652A (ja) 2003-11-04 2011-09-29 遺伝子導入された樹状細胞の製造方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2005515163A Division JPWO2005042737A1 (ja) 2003-11-04 2004-10-29 遺伝子導入された樹状細胞の製造方法

Publications (2)

Publication Number Publication Date
JP2012065652A JP2012065652A (ja) 2012-04-05
JP2012065652A5 true JP2012065652A5 (enExample) 2012-12-20

Family

ID=34554806

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2005515163A Withdrawn JPWO2005042737A1 (ja) 2003-11-04 2004-10-29 遺伝子導入された樹状細胞の製造方法
JP2011214253A Pending JP2012065652A (ja) 2003-11-04 2011-09-29 遺伝子導入された樹状細胞の製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2005515163A Withdrawn JPWO2005042737A1 (ja) 2003-11-04 2004-10-29 遺伝子導入された樹状細胞の製造方法

Country Status (8)

Country Link
US (1) US20070269414A1 (enExample)
EP (1) EP1690937B1 (enExample)
JP (2) JPWO2005042737A1 (enExample)
KR (1) KR101279748B1 (enExample)
CN (1) CN1902312B (enExample)
AU (1) AU2004286144A1 (enExample)
CA (1) CA2544786A1 (enExample)
WO (1) WO2005042737A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2236378C (en) 1995-11-01 2011-01-25 Dnavec Research Inc. Recombinant sendai virus
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
JPWO2001072340A1 (ja) * 2000-03-30 2004-01-08 株式会社ディナベック研究所 センダイウイルスベクターを用いたａｉｄｓウイルスワクチン
JP2002142770A (ja) * 2000-11-08 2002-05-21 Dnavec Research Inc 循環系への遺伝子送達用パラミクソウイルスベクター
CN1732267A (zh) * 2002-10-24 2006-02-08 株式会社载体研究所 将基因转导入t细胞中的方法
KR20060028432A (ko) * 2003-06-30 2006-03-29 가부시키가이샤 디나벡크 겐큐쇼 고변이영역이 개변된 유전자를 탑재하는 마이너스가닥 ｒｎａ 바이러스 벡터
US20070269414A1 (en) * 2003-11-04 2007-11-22 Shinji Okano Method for Producing Gene Transferred Denritic Cells
KR20060129013A (ko) * 2004-01-13 2006-12-14 가부시키가이샤 디나벡크 겐큐쇼 면역자극성 사이토카인을 코드하는 마이너스 가닥 ｒｎａ 바이러스 벡터를 사용하는 종양의 유전자 치료
US20080038234A1 (en) * 2004-03-23 2008-02-14 Shuji Hayashi Bone Marrow-Related Cells Associated With Tissue Maintenance And/Or Repair
EP1775343A4 (en) * 2004-06-24 2007-11-14 Dnavec Research Inc ANTITUM-AGENT WITH DENDRITIC CELL WITH THE TRANSFECTED RNA VIRUS
WO2006134917A1 (ja) * 2005-06-14 2006-12-21 Dnavec Corporation 抗体の作製方法
KR20080094910A (ko) * 2006-01-17 2008-10-27 디나벡크 가부시키가이샤 신규 단백질 발현계
EP2143794A1 (en) * 2007-04-27 2010-01-13 Kyushu University, National University Corporation Viral vector for gene therapy
CN101755045B (zh) * 2007-05-17 2014-02-12 生物载体株式会社 树突状细胞的制备方法
EP2173374A2 (en) * 2007-07-24 2010-04-14 Stichting Katholieke Universiteit, Radboud University Nijmegen Medical Centre Compositions and methods for generating an immune response in a subject
JP2010537629A (ja) * 2007-08-30 2010-12-09 アカデミシュ ジーケンハウス ビイ デ ユニヴェアズィテート ファン アムステルダム 動脈形成に関与する経路及びその使用
WO2009111396A1 (en) * 2008-03-03 2009-09-11 University Of Toledo Dendritic cell precursor populations, dendritic cell populations derived therefrom and uses thereof
WO2010055900A1 (ja) 2008-11-14 2010-05-20 ディナベック株式会社 樹状細胞の製造方法
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
WO2020237315A1 (en) * 2019-05-31 2020-12-03 Telethon Kids Institute Immunogenic compositions

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6147186A (ja) 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst インフルエンザウイルスの精製方法
JPS6147185A (ja) 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst 日本脳炎ウイルスの精製方法
JPS6147187A (ja) 1984-08-10 1986-03-07 Chemo Sero Therapeut Res Inst 狂犬病ウイルスの精製方法
JPH084508B2 (ja) 1987-09-16 1996-01-24 国立予防衛生研究所長 組み換えワクチニアウイルス
US5124148A (en) * 1988-04-27 1992-06-23 United Cancer Research Institute Method for treating viral diseases with attenuated virus
JPH01285498A (ja) 1988-05-11 1989-11-16 Mitsubishi Heavy Ind Ltd 宇宙用パネル展開装置
TW232710B (enExample) 1991-09-13 1994-10-21 American Cyanamid Co
JPH05192160A (ja) 1992-01-20 1993-08-03 Banyu Pharmaceut Co Ltd Ｃ型肝炎ウイルスゲノムＲＮＡ、ｃＤＮＡ及びポリペプチド
JPH07502173A (ja) 1992-10-06 1995-03-09 アクゾ・ノベル・エヌ・ベー 偽性狂犬病ウイルスワクチン
US6077519A (en) * 1993-01-29 2000-06-20 University Of Pittsburgh Methods for isolation and use of T cell epitopes eluted from viable cells in vaccines for treating cancer patients
AU699487B2 (en) * 1993-04-30 1998-12-03 Robert M. Lorence Methods of treating and detecting cancer using viruses
US5744144A (en) 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
US5798100A (en) 1994-07-06 1998-08-25 Immunomedics, Inc. Multi-stage cascade boosting vaccine
US6300090B1 (en) * 1994-07-29 2001-10-09 The Rockefeller University Methods of use of viral vectors to deliver antigen to dendritic cells
KR100754091B1 (ko) * 1995-10-31 2007-08-31 가부시끼가이샤 디나벡 겡뀨쇼 자율 복제 능력을 갖는 (-)쇄 ｒｎａ 바이러스 벡터
CA2236378C (en) 1995-11-01 2011-01-25 Dnavec Research Inc. Recombinant sendai virus
US6734014B1 (en) * 1996-02-08 2004-05-11 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for transforming dendritic cells and activating T cells
AU1733697A (en) 1996-02-29 1997-09-16 Takara Shuzo Co., Ltd. Method of purifying and removing viruses
AU7499498A (en) * 1997-05-21 1998-12-11 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and compositions for making dendritic cells from expanded populations ofmonocytes and for activating t cells
CA2368944C (en) 1999-05-18 2010-07-27 Dnavec Research Inc. Paramyxovirus-derived rnp
US7226786B2 (en) * 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
US20030022376A1 (en) * 1999-05-18 2003-01-30 Kaio Kitazato Paramyxovirus-derived RNP
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
CA2368948C (en) 1999-05-18 2013-12-24 Dnavec Research Inc. Envelope gene-deficient virus vector of paramyxoviridae
EP1067179A1 (en) 1999-07-09 2001-01-10 Pierre Fabre Medicament Method to select attenuated paramyxoviridae useful for vaccines and therapeutics
US20020123479A1 (en) * 1999-12-08 2002-09-05 Song Elizabeth S. Immunostimulation mediated by gene-modified dendritic cells
US6472208B1 (en) * 1999-12-13 2002-10-29 Héma-Québec Method of producing human IFN-α using sendai virus-infected hematopoietic stem cells
JPWO2001072340A1 (ja) * 2000-03-30 2004-01-08 株式会社ディナベック研究所 センダイウイルスベクターを用いたａｉｄｓウイルスワクチン
CA2322057A1 (en) * 2000-05-18 2001-11-18 Dnavec Research Inc. Paramyxovirus vectors used for transfer of foreign genes
WO2002090510A2 (en) * 2001-05-08 2002-11-14 Emory University Regulating immine responses using dendritic cells
CA2452691A1 (en) * 2001-07-05 2003-01-16 Phylogix, Inc. Dendritic cell isolation methods
PT2322603T (pt) * 2001-09-06 2020-01-21 Northwest Biotherapeutics Inc Composições e métodos para ativaçao linfocitária de células dendríticas monocíticas e células para resposta th-1
CN1633599A (zh) * 2001-09-18 2005-06-29 株式会社载体研究所 检查和制造降低了粒子形成能力的(－)链rna载体的方法
JPWO2003029475A1 (ja) * 2001-09-28 2005-01-20 株式会社ディナベック研究所 エピトープ結合β２ｍをコードする哺乳動物細胞感染性ウイルスベクターおよびその利用
US20050048030A1 (en) * 2001-09-28 2005-03-03 Raymond Pickles Paramyxoviruses as gene transfer vectors to lung cells
FR2838123B1 (fr) * 2002-04-04 2005-06-10 Sanofi Synthelabo Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf
US20050191617A1 (en) * 2002-06-03 2005-09-01 Makoto Inoue Pramyxovirusl vectors encoding antibody and utilization thereof
AU2002951082A0 (en) * 2002-08-30 2002-09-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic cellular agents
CN1732267A (zh) * 2002-10-24 2006-02-08 株式会社载体研究所 将基因转导入t细胞中的方法
WO2004053095A2 (en) * 2002-12-10 2004-06-24 Merix Bioscience, Inc. In situ maturation of dendritic cells
US20070269414A1 (en) * 2003-11-04 2007-11-22 Shinji Okano Method for Producing Gene Transferred Denritic Cells
KR20060129013A (ko) * 2004-01-13 2006-12-14 가부시키가이샤 디나벡크 겐큐쇼 면역자극성 사이토카인을 코드하는 마이너스 가닥 ｒｎａ 바이러스 벡터를 사용하는 종양의 유전자 치료
US8741650B2 (en) * 2004-01-22 2014-06-03 Dnavec Research Inc. Methods for producing minus-strand RNA viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken β-actin promoter
WO2005087269A1 (ja) * 2004-03-16 2005-09-22 Dnavec Research Inc. 腫瘍増殖を抑制する方法
US20080038234A1 (en) * 2004-03-23 2008-02-14 Shuji Hayashi Bone Marrow-Related Cells Associated With Tissue Maintenance And/Or Repair
EP1775343A4 (en) * 2004-06-24 2007-11-14 Dnavec Research Inc ANTITUM-AGENT WITH DENDRITIC CELL WITH THE TRANSFECTED RNA VIRUS
AU2006237903A1 (en) * 2005-04-20 2006-10-26 Dna Vec Corporation Highly safe intranasally administrable gene vaccines for treating Alzheimer's disease
EP2034014A1 (en) * 2006-05-31 2009-03-11 Dnavec Corporation Therapeutic agent for alzheimer's disease
CN101755045B (zh) * 2007-05-17 2014-02-12 生物载体株式会社 树突状细胞的制备方法

Similar Documents

Publication Publication Date Title
JP2012065652A5 (enExample)
JP2012130346A5 (enExample)
JP2016537982A5 (enExample)
JP2019505164A5 (enExample)
JP2016528894A5 (enExample)
WO2013049121A3 (en) Recombinant phage and methods
JP2016501515A5 (enExample)
JP2012050449A5 (enExample)
JP2013531978A5 (enExample)
JP2016518142A5 (enExample)
JP2015165823A5 (enExample)
JP2016500260A5 (enExample)
JP2017524348A5 (enExample)
JP2016539627A5 (enExample)
JP2010500029A5 (enExample)
JP2016539641A5 (enExample)
JP2013516982A5 (enExample)
JP2013530680A5 (enExample)
JP2013517776A5 (enExample)
JP2014511118A5 (enExample)
IL232662B (en) Process for producing virus-like particles comprising enterobacteriophage ms2 capsid proteins
JP2017536826A5 (enExample)
WO2013033308A3 (en) Methods for tissue culture and transformation of sugarcane
MX2021009554A (es) Produccion de virus en cultivos celulares.
EA201690232A1 (ru) Генетически стабильный онколитический рнк вирус, способ его производства и применения